The purpose of this phase 3 study is to compare the efficacy and safety of chronic ursodeoxycholic acid (UDCA) therapy vs. the combination of UDCA and methotrexate (MTX) therapy in patients with primary biliary cirrhosis (PBC).
Showing the most recent 10 out of 563 publications